Efektivitas Cognitive Behavior Therapy pada Pecandu Narkoba: Systematic Literature Review

Cici Listy Utami; Made Suandika; Fauziah Hanum

doi:10.55681/sentri.v5i3.6049

Authors

Cici Listy Utami Program Studi Anestesiologi, Fakultas Kesehatan, Universitas Harapan Bangsa
Made Suandika Program Studi Anestesiologi, Fakultas Kesehatan, Universitas Harapan Bangsa
Fauziah Hanum Program Studi Anestesiologi, Fakultas Kesehatan, Universitas Harapan Bangsa

DOI:

https://doi.org/10.55681/sentri.v5i3.6049

Keywords:

Cognitive Behavioral Therapy, Substance Use Disorder, Drug Addiction, Relapse

Abstract

Drug abuse is a global health issue that affects physical, psychological, and social aspects. In Indonesia, the prevalence of drug abuse remains high, particularly among people of working age. Cognitive Behavioral Therapy (CBT) is an evidence-based psychosocial intervention widely used in the rehabilitation of drug addicts. This study aims to evaluate the effectiveness of cognitive behavioral therapy for drug addicts. A systematic review was conducted in accordance with the PRISMA 2020 guidelines through searches in PubMed, ScienceDirect, and Taylor & Francis from 2015 to 2025. Articles meeting the inclusion criteria were randomized controlled trials (RCTs) assessing the effectiveness of CBT in drug users. Methodological quality was assessed using the Joanna Briggs Institute (JBI) instrument. A total of 9 articles met the inclusion criteria. The synthesis results indicate that CBT is effective in reducing the frequency of drug use, lowering the risk of relapse, and improving psychological symptoms such as depression and anxiety. CBT also enhances patients’ self-efficacy and self-esteem. The combination of CBT with pharmacotherapy yields more optimal results compared to monotherapy. CBT is an effective intervention in drug addiction rehabilitation as it reduces substance use and improves psychological well-being. CBT is recommended as an evidence-based approach in addiction rehabilitation services.

Downloads

Download data is not yet available.

References

S. M. A. Alavi, R. D. Irani, P. Fattahi, and S. Pakseresht, “Effects of brief cognitive behavioral therapy on mental health in substance-related disorder: A randomized controlled trial,” BMC Psychiatry, vol. 23, no. 1, 2023. doi: 10.1186/s12888-023-05413-4.

A. Alya Attiah, “Cognitive behavioral therapy treatment for drug addiction,” Journal of Addiction Therapy and Research, vol. 7, no. 1, pp. 5–7, 2023. doi: 10.29328/journal.jatr.1001025.

L. Ashrafioun, N. P. Allan, and T. A. Stecker, “A randomized clinical trial to assess feasibility, acceptability and preliminary effects of telehealth-delivered cognitive-behavioral therapy for perceived social isolation among individuals with opioid use disorders,” Drug and Alcohol Dependence, vol. 258, 2024. doi: 10.1016/j.drugalcdep.2024.111268.

Badan Narkotika Nasional, Hindari Narkotika Cerdaskan Generasi Muda Bangsa, Indonesia Drugs Report 2023. Jakarta: Puslitdatin BNN, 2023. [Online]. Available: https://bnn.go.id/hindari-narkotika-cerdaskan-generasi-muda-bangsa/

K. M. Carroll and B. D. Kiluk, “Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again,” Psychology of Addictive Behaviors, vol. 31, no. 8, pp. 847–861, 2017. doi: 10.1037/adb0000311.

R. Ismail et al., “Predictors of drug and substance abuse among school-going adolescents living in drug hotspot in Malaysia,” PLoS ONE, vol. 19, no. 6, 2024. doi: 10.1371/journal.pone.0305460.

B. D. Kiluk et al., “Randomized clinical trial of computerized and clinician-delivered CBT in comparison with standard outpatient treatment for substance use disorders: Primary within-treatment and follow-up outcomes,” American Journal of Psychiatry, vol. 175, no. 9, pp. 853–863, 2018. doi: 10.1176/appi.ajp.2018.17090978.

A. Kräplin et al., “Personality traits predict non-substance related and substance related addictive behaviours: A prospective study,” Sucht, vol. 68, no. 5, pp. 263–277, 2022. doi: 10.1024/0939-5911/a000780.

M. Magill et al., “A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition,” Journal of Consulting and Clinical Psychology, vol. 87, no. 12, pp. 1093–1105, 2019. doi: 10.1037/ccp0000447.

J. Marsden et al., “Memory-focused cognitive therapy for cocaine use disorder: Rationale, design and protocol for an external pilot randomised controlled trial,” Contemporary Clinical Trials Communications, vol. 8, pp. 264–273, 2017. doi: 10.1016/j.conctc.2017.10.009.

R. K. McHugh, A. J. Bailey, R. D. Weiss, and G. M. Fitzmaurice, “Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder,” Drug and Alcohol Dependence Reports, vol. 11, 2024. doi: 10.1016/j.dadr.2024.100226.

S. Pan et al., “Efficacy of cognitive behavioral therapy on opiate use and retention in methadone maintenance treatment in China: A randomised trial,” PLoS ONE, vol. 10, no. 6, 2015. doi: 10.1371/journal.pone.0127598.

P. Program et al., “Pengaruh cognitive behavioral therapy (CBT) terhadap self-esteem pengguna methamphetamine,” Journal of Muslim Community Health (JMCH), vol. 3, no. 2, pp. 24–34, 2022. doi: 10.52103/jmch.v3i2.858.

J. Ross et al., “The efficacy of behavioural activation treatment for co-occurring depression and substance use disorder (the activate study): A randomized controlled trial,” BMC Psychiatry, vol. 16, no. 1, 2016. doi: 10.1186/s12888-016-0943-1.

M. Susanti, I. A. Dania, and F. Ibarra, “Self-efficacy reduces relapse in drug abuse with cognitive behaviour therapy,” Jurnal Ilmiah Ilmu Terapan Universitas Jambi, vol. 8, no. 2, pp. 784–793, 2024. doi: 10.22437/jiituj.v8i2.34358.

S. T. Tong et al., “Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: Protocol for a randomized controlled trial,” Addiction Science and Clinical Practice, vol. 19, no. 1, 2024. doi: 10.1186/s13722-024-00498-y.

K. D. Wagner et al., “Cognitive behavioral theories used to explain injection risk behavior among injection drug users: A review and suggestions for the integration of cognitive and environmental models,” Health Education and Behavior, vol. 37, no. 4, pp. 504–532, 2010. doi: 10.1177/1090198109357319.

K. Wolitzky-Taylor et al., “Augmenting the efficacy of benzodiazepine taper with telehealth-delivered cognitive behavioral therapy for anxiety disorders in patients using prescription opioids: A pilot randomized controlled trial,” Contemporary Clinical Trials, vol. 133, 2023. doi: 10.1016/j.cct.2023.107334.